A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors.

scientific article published in November 1988

A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0002-8703(88)90133-0
P698PubMed publication ID2903652

P2093author name stringJ M Herrmann
E O Mayer
P433issue5 Pt 2
P407language of work or nameEnglishQ1860
P304page(s)1416-1421
P577publication date1988-11-01
P1433published inAmerican Heart JournalQ2227156
P1476titleA long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors.
P478volume116

Reverse relations

cites work (P2860)
Q40624637A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease
Q40621879Antihypertensive drugs: issues beyond blood pressure control
Q40953069Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris
Q36676469Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease
Q36482914Clinical perspective on celiprolol: Cardioprotective potential
Q67897406Clinical safety and efficacy of celiprolol
Q72772554Effects of celiprolol vs. nifedipine on serum lipoproteins in patients with mild to moderate hypertension
Q41875844Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients
Q51581362Effects of oral albuterol on serum lipids and carbohydrate metabolism in healthy men.
Q68291248Hypertension with concomitant conditions: The changing role of β-adrenoceptor blockade
Q44431760Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
Q36482909Metabolic considerations in the choice of therapy for the patient with hypertension
Q40923118New approaches to the prevention of atherosclerosis
Q41560071Pharmacological approaches and strategies for therapeutic modulation of fibrinogen
Q68292780The effects of cardioselective vasodilating β-blockers on lipids
Q37119116The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients
Q71618741Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension

Search more.